CAVALETTI, GUIDO ANGELO

CAVALETTI, GUIDO ANGELO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 701 (tempo di esecuzione: 0.031 secondi).
Titolo Tipologia Data di pubblicazione Autori File
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata 01 - Articolo su rivista 2024 Cavaletti G. +
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 02 - Intervento a convegno 2024 Valentina Alda CarozziVirginia Rodriguez-MenendezEleonora PozziAnnalisa CantaAlessia ChiorazziElisa BallariniPaola AlbertiCristina MeregalliNicoletta CordaniDaniele RamazzottiAlberto BravinGuido Cavaletti +
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 02 - Intervento a convegno 2024 Carozzi VAPozzi ECanta AChiorazzi ACordani NAlberti PMeregalli CCavaletti G +
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 02 - Intervento a convegno 2024 Invernizzi, CPozzi, ECanta, AChiorazzi, ABallarini, ERodriguez Menendez, VCavaletti, GAlberti P +
Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study 01 - Articolo su rivista 2024 Cavaletti G. +
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 02 - Intervento a convegno 2024 Pozzi, EArgentini, ACanta, AAlberti, PMeregalli, CCherchi, LCavaletti, GCarozzi VA +
Histone deacetylase 6 inhibitors and neuroprotection: evidences and molecular mechanisms 02 - Intervento a convegno 2024 Squarzoni, ADonzelli, ECavaletti, GScuteri, A +
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 01 - Articolo su rivista 2024 Cavaletti G. +
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 02 - Intervento a convegno 2024 Meregalli ,CChiorazzi, AArgentini, ABallarini, ElisaCanta, ACarozzi VMalacrida, AMarmiroli, PTarasiuk, OCavaletti, G
Mobile Applications to Support Multiple Sclerosis Communities: The Post-COVID-19 Scenario 01 - Articolo su rivista 2024 Vacchi L.Strina V.Cavaletti G.Ferrarese C. +
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 02 - Intervento a convegno 2024 Tarasiuk, OPozzi, ECanta AChiorazzi, ACarozzi, VBallarini, EArgentini, AFoti, MCavaletti, GMeregalli, C +
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 02 - Intervento a convegno 2024 Alberti, PPozzi, ECapelli, CInvernizzi, CChiorazzi, ABallarini, ECavaletti, G +
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 02 - Intervento a convegno 2024 Malacrida, ATarasiuk, ONicolini, GCavaletti, GMeregalli, C +
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 01 - Articolo su rivista 2024 Cavaletti, GuidoAlberti, PaolaCanta, AnnalisaCarozzi, ValentinaCherchi, LauraChiorazzi, AlessiaCrippa, LucaMarmiroli, PaolaMeregalli, CristinaPozzi, EleonoraRodriguez-Menendez, VirginiaLicandro, Simonetta Andrea +
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 02 - Intervento a convegno 2023 Alberti, PCanta, AChiorazzi, APozzi, EBallarini, EMarmiroli, PCavaletti, G +
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 01 - Articolo su rivista 2023 Malacrida A.Rigolio R.Cavaletti G.Miloso M. +
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence 01 - Articolo su rivista 2023 Cavaletti, GuidoAlberti, Paola +
CIPN and its mechanism of development 02 - Intervento a convegno 2023 Tarasiuk, OPozzi, ECanta, AChiorazzi, ABallarini, EFoti, MCavaletti, GMeregalli, C +
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome 01 - Articolo su rivista 2023 Cavaletti G. +
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials 01 - Articolo su rivista 2023 Schilke E. D.Remoli G.Funelli E.Galimberti M.Fusco M. L.Cereda D.Balducci C.Frigo M.Cavaletti G.